CUSIP 462260100COMIOVAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
261 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 29.52M | $80.58M | +3.56M | Added |
| 2 | Mhr Fund Management LLC | 28.97M | $79.08M | 0 | Held |
| 3 | Vanguard Group Inc | 27.21M | $74.28M | +3.15M | Added |
| 4 | State Street Corp | 20.16M | $55.04M |
| Added |
| 5 | Bank Of America Corp /De/ | 14.28M | $38.98M | +8.00M | Added |
| 6 | Invenomic Capital Management LP | 11.96M | $32.65M | +1.42M | Added |
| 7 | Morgan Stanley | 9.19M | $25.09M | +3.61M | Added |
| 8 | Goldman Sachs Group Inc | 8.61M | $23.50M | +2.03M | Added |
| 9 | Long Focus Capital Management, LLC | 8.60M | $23.48M | −516.5K | Reduced |
| 10 | Geode Capital Management, LLC | 7.99M | $21.82M | +1.12M | Added |
See every fund holding Iovance Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders